Evolution of the Average Target: DR Horton

Evolution of the Average Target - DR Horton

Evolution of the Target Price: DR Horton

Evolution of the Target Price - DR Horton

Changes in Analyst Recommendations: DR Horton

f84333a20af1019a.Lw_xRFtGcR2vHIdqq66UmkHF4EyYtjianfoCBZfwFLE.cEirAhgjBCvsctEwxpfN03SEunrMmwn1_KtTRqCYYP5lfZYgbxAacehm8A~dedac1e3e95cb97ac34e0f6cde28baea
10-16 Wells Fargo Adjusts Price Target on D.R. Horton to $140 From $145 MT
10-15 RBC Capital Adjusts Price Target on D.R. Horton to $119 From $125, Keeps Underperform Rating MT
10-15 Citigroup Adjusts Price Target on D.R. Horton to $150 From $160 MT
10-13 D.R. Horton Faces Slower Home Sales, Margin Pressure, Oppenheimer Says MT
10-12 D.R. Horton Starting to Look More Attractive, Truist Says MT
10-12 Goldman Sachs Adjusts Price Target on D.R. Horton to $182 From $190 MT
10-08 Evercore ISI Adjusts Price Target on D.R. Horton to $166 From $171 MT
10-07 BofA Securities Adjusts Price Target on D.R. Horton to $145 From $150 MT
10-06 Barclays Adjusts D.R. Horton Price Target to $130 From $141, Maintains Equal Weight Rating MT
10-01 Morgan Stanley Initiates D.R. Horton at Equalweight With $151 Price Target MT
09-25 Evercore ISI Adjusts Price Target on D.R. Horton to $166 From $177, Maintains In Line Rating MT
09-22 Keefe Bruyette & Woods Adjusts PT on D.R. Horton to $160 From $167, Keeps Market Perform Rating MT
09-22 BTIG Adjusts Price Target on D.R. Horton to $174 From $184, Keeps Buy Rating MT
09-21 Keefe, Bruyette & Woods Adjusts Price Target on D.R. Horton to $160 From $167 MT
09-18 Wall Street's Relief Has Limits Zonebourse
09-16 Meritage Homes Likely to Increase Homebuyer Incentives Amid High Mortgage Rates, Truist Says MT
09-16 Truist Cuts Price Target on D.R. Horton to $140 From $150, Keeps Hold Rating MT
09-11 Wells Fargo Adjusts Price Target on D.R. Horton to $145 From $155, Maintains Equalweight Rating MT
08-04 Wells Fargo Adjusts Price Target on D.R. Horton to $155 From $170, Maintains Equalweight Rating MT
07-22 Citigroup Adjusts Price Target on D.R. Horton to $160 From $173, Maintains Neutral Rating MT
07-22 BTIG Adjusts Price Target on D.R. Horton to $184 From $188, Maintains Buy Rating MT
07-22 RBC Lifts Price Target on D.R. Horton to $125 From $123, Keeps Underperform Rating MT
07-22 Keefe Bruyette & Woods Adjusts PT on D.R. Horton to $167 From $175, Maintains Market Perform Rating MT
07-22 Goldman Sachs Adjusts Price Target on D.R. Horton to $190 From $186, Maintains Buy Rating MT
07-22 Evercore ISI Adjusts Price Target on D.R. Horton to $177 From $171, Maintains In Line Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+13.02%
+22.05%
+2.63%
+11.53%
+9.73%
+11.34%
+28.76%
+3.43%
+8.69%
Average +12.35%
Weighted average by Cap. +13.03%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
21
Last Close Price
135.31USD
Average target price
152.93USD
Spread / Average Target
+13.02%
High Price Target
206.00USD
Spread / Highest target
+52.24%
Low Price Target
119.00USD
Spread / Lowest Target
-12.05%

Analyst Consensus Detail

Analyst consensus - DR Horton

Consensus revision (last 18 months)

Consensus revision (last 18 months) - DR Horton
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - DR Horton